NCT03511963 2024-12-31
A Clinical Study to Compare the Efficacy, Safety and Immunogenicity of HLX04 and Bevacizumab Combined XELOX or mFOLFOX6 in the First-line Treatment of mCRC
Shanghai Henlius Biotech
Phase 3 Completed
Clinical Trials
11 trialsNCT04676633 2024-03-19
Safety, Tolerability, PK, Anti-Tumor Activity of STP705 in Subjects With Advanced/Metastatic or Surgically Unresectable Solid Tumors Who Are Refractory to Standard Therapy
Sirnaomics
Phase 1 Completed
NCT05765357 2023-03-13
Clinical Study to Compare the Pharmacokinetics and Safety of Trastuzumab for Injection With HerceptinĀ® in Healthy Male Volunteers
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 1 Completed
NCT04295330 2022-08-26
Efficacy of Intravenous Lidocaine on Postoperative Pain and Recovery in Patients Undergoing Hepatectomy
West China Hospital
Phase NA Completed
NCT03556345 2022-01-13
A Study of RC48-ADC in Local Advanced or Metastatic Gastric Cancer Subjects With the Overexpression of HER2
RemeGen Co., Ltd.
Phase 2 Completed
NCT04642664 2021-06-03
ACABC
Peking Union Medical College Hospital
Phase 2 Completed
NCT02301481 2019-10-16
A Randomized Phase II Trial of Neoadjuvant Chemotherapy Compared With Chemoradiotherapy in Gastric Adenocarcinoma
ChineseAMS
Phase 2 Completed
NCT02382237 2017-08-21
PETANC
Institut du Cancer de Montpellier - Val d'Aurelle
Phase NA Completed
NCT01386242 2016-01-05
Recombinant Anti-tumor and Anti-virus Protein for Injection in Treatment of Metastatic Colorectal Cancer
The Affiliated Hospital of the Chinese Academy of Military Medical Sciences
Phase 2 Completed
NCT00123318 2013-06-18
A Feasibility Study to Evaluate Adjuvant Chemoradiotherapy for Gastric Cancer
Trans Tasman Radiation Oncology Group
Phase 3 Completed
NCT00041808 2005-06-24
Magnetic-Targeted Doxorubicin in Treating Patients With Cancer Metastatic to the Liver
FeRx
Phase 1/2 Completed